EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-27b-3p Exacerbates VCD-Induced KGN Cell Injury by Targeting PAPPA to Suppress IGF-1 Release and Inhibit the PI3K/AKT Pathway

Manyu Zhang, Xiangyu Meng, Mengdi Shi, Pengling Ge iD

Genes · 18.08.2026 · 17 (8) · 966

DOI: 10.3390/genes17080966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 18.08.2026. Verfasst von Manyu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: MicroRNAs, Insulin-Like Growth Factor I, Granulosa Cells, Pregnancy-Associated Plasma Protein-A. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: While currently termed premature ovarian insufficiency (POI), premature ovarian failure (POF) remains a prominent driver of female infertility with a molecular pathogenesis that is still lacking comprehensive clarification. In in vitro studies, the pathology of POI is commonly simulated through a well-characterized model involving VCD (4-vinylcyclohexene diepoxide)-mediated cytotoxicity within KGN-derived human granulosa cells. However, the key regulatory molecular networks involved in this process are still poorly characterized. Although microRNAs (miRNAs) have emerged as critical regulators in ovarian function decline, the specific role and underlying mechanism of miR-27b-3p in POI remain elusive.

Methods

A VCD-induced KGN cell injury model was established by treating cells with 1.0 mM VCD for 24 h. Cell viability, apoptosis rate, and miR-27b-3p expression were assessed by CCK-8 assay, flow cytometry, and RT-qPCR, respectively. Overexpression and targeted suppression of miR-27b-3p were achieved by introducing its specific mimics and inhibitors, respectively. Target identification was conducted via bioinformatic prediction, EdU incorporation, Western blot, and dual-luciferase reporter assays. Functional rescue experiments were carried out by co-transfection with a PAPPA-overexpressing plasmid (oe-PAPPA). IGF-1 secretion was quantified by ELISA, and phosphorylation of IGF1R and AKT was analyzed by Western blot to determine whether miR-27b-3p modulates cellular phenotypes via the PAPPA–IGF-1–PI3K/AKT axis. Exogenous IGF-1 supplementation was further applied to confirm pathway dependence.

Results

VCD treatment dose-dependently restrained cellular growth and stimulated apoptotic pathways in KGN cells; paralleling these phenotypic changes, miR-27b-3p abundance was remarkably increased. Ectopic expression of miR-27b-3p exacerbated VCD-induced growth inhibition and apoptosis, whereas its inhibition conferred cytoprotective effects. Through the integration of computational predictions and dual-luciferase reporter systems, PAPPA was definitively established as a direct downstream target of miR-27b-3p. miR-27b-3p negatively regulated both PAPPA mRNA and protein levels, thereby impairing PAPPA-mediated cleavage of IGF-binding proteins (e.g., IGFBP4) and subsequent release of free IGF-1. This led to reduced IGF-1 secretion and significantly diminished phosphorylation of IGF1R and AKT. Remarkably, PAPPA overexpression effectively reversed the detrimental effects of miR-27b-3p, and exogenous IGF-1 supplementation similarly attenuated miR-27b-3p–mediated proliferation arrest and pro-apoptotic phenotypes.

Conclusions

This study uncovers a novel pathogenic mechanism whereby miR-27b-3p exacerbates VCD-induced granulosa cell injury by directly targeting PAPPA, suppressing IGF-1 release, and consequently inhibiting the PI3K/AKT pro-survival signaling pathway. A novel perspective on the fundamental basis of POI is established by this research, which further posits therapeutic manipulation of the miR-27b-3p/PAPPA/IGF-1 module as a prospective treatment for disrupted ovarian function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsInsulin-Like Growth Factor IGranulosa CellsPregnancy-Associated Plasma Protein-APrimary Ovarian InsufficiencyCyclohexenesHumansFemaleProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionApoptosisVinyl CompoundsCell SurvivalCell Line

Stichwörter der Autor:innen

IGF-1/PI3K/AKT pathwayPAPPAVCD-induced injury modelmiR-27b-3povarian granulosa cellspremature ovarian insufficiency (POI)

Substanzen

MicroRNAsInsulin-Like Growth Factor IProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMIRN27b microRNA, humanPregnancy-Associated Plasma Protein-AMIRN27 microRNA, humanCyclohexenesIGF1 protein, humanVinyl Compounds

Autor:innen und Institutionen

  • Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • Department of Medical History and Literature of TCM, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • Department of Medical Affairs, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.

ORCID-Profile: Pengling Ge

Zitieren

APA

Zhang, M., Meng, X., Shi, M., & Ge, P. (2026). miR-27b-3p Exacerbates VCD-Induced KGN Cell Injury by Targeting PAPPA to Suppress IGF-1 Release and Inhibit the PI3K/AKT Pathway. Genes, 17(8), 966. https://doi.org/10.3390/genes17080966

Vancouver

Zhang M, Meng X, Shi M, Ge P. miR-27b-3p Exacerbates VCD-Induced KGN Cell Injury by Targeting PAPPA to Suppress IGF-1 Release and Inhibit the PI3K/AKT Pathway. Genes. 2026;17(8):966. doi:10.3390/genes17080966

BibTeX
@article{Zhang2026,
  author = {Zhang, Manyu and Meng, Xiangyu and Shi, Mengdi and Ge, Pengling},
  title = {miR-27b-3p Exacerbates VCD-Induced KGN Cell Injury by Targeting PAPPA to Suppress IGF-1 Release and Inhibit the PI3K/AKT Pathway},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {8},
  pages = {966},
  doi = {10.3390/genes17080966}
}
Kostenlos starten →